These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30334469)

  • 41. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A.
    Bamford NS; White KK; Robinett SA; Otto RK; Gospe SM
    Dev Med Child Neurol; 2009 May; 51(5):408-11. PubMed ID: 19388151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of gait impairments in people with Charcot-Marie-Tooth disease: A treatment algorithm.
    Nonnekes J; Hofstad C; de Greef-Rotteveel A; van der Wielen H; van Gelder JH; Plaats C; Altmann V; Krause F; Keijsers N; Geurts A; Louwerens JWK
    J Rehabil Med; 2021 May; 53(5):jrm00194. PubMed ID: 33880570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin treatment of pes cavovarus in a child suffering from autosomal recessive axonal Charcot-Marie-Tooth neuropathy (AR-CMT2).
    Tiffreau V; Allart E; Dangleterre C; Boutry N; Petit F; Cuisset JM; Thevenon A
    Eur J Phys Rehabil Med; 2015 Jun; 51(3):345-9. PubMed ID: 24980632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychological distress in patients with Charcot-Marie-Tooth disease.
    Vinci P; Gargiulo P; Panunzi M; Baldini L
    Eur J Phys Rehabil Med; 2009 Sep; 45(3):385-9. PubMed ID: 19182736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with foot and ankle strength in healthy preschool-age children and age-matched cases of Charcot-Marie-Tooth disease type 1A.
    Rose KJ; Burns J; North KN
    J Child Neurol; 2010 Apr; 25(4):463-8. PubMed ID: 19671887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
    Boyer O; Nevo F; Plaisier E; Funalot B; Gribouval O; Benoit G; Huynh Cong E; Arrondel C; Tête MJ; Montjean R; Richard L; Karras A; Pouteil-Noble C; Balafrej L; Bonnardeaux A; Canaud G; Charasse C; Dantal J; Deschenes G; Deteix P; Dubourg O; Petiot P; Pouthier D; Leguern E; Guiochon-Mantel A; Broutin I; Gubler MC; Saunier S; Ronco P; Vallat JM; Alonso MA; Antignac C; Mollet G
    N Engl J Med; 2011 Dec; 365(25):2377-88. PubMed ID: 22187985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study.
    Ferrarin M; Lencioni T; Rabuffetti M; Moroni I; Pagliano E; Pareyson D
    J Neuroeng Rehabil; 2013 Jul; 10():65. PubMed ID: 23819439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Foot measures in patients with pes cavus with and without charcot-marie-tooth disease: A pilot study.
    Stino AM; Atway S; Anthony M; Kline D; Kissel JT
    Muscle Nerve; 2019 Jan; 59(1):122-125. PubMed ID: 30039580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microstructural Integrity of Peripheral Nerves in Charcot-Marie-Tooth Disease: An MRI Evaluation Study.
    Cheah PL; Krisnan T; Wong JHD; Rozalli FI; Fadzli F; Rahmat K; Shahrizaila N; Tan LK; Nawawi O; Ramli N
    J Magn Reson Imaging; 2021 Feb; 53(2):437-444. PubMed ID: 32918328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
    Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS
    Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orthopaedic shoes improve gait in a Charcot-Marie-Tooth patient: a combined clinical and quantified case study.
    Guzian MC; Bensoussan L; Viton JM; Mihle de Bovis V; Ramon J; Azulay JP; Delarque A
    Prosthet Orthot Int; 2006 Apr; 30(1):87-96. PubMed ID: 16739785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Charcot neuroarthropathy in patients with Charcot Marie Tooth Disease.
    Singh D; Gray J; Laura M; Reilly MM
    Foot Ankle Surg; 2021 Dec; 27(8):865-868. PubMed ID: 33272751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.
    Wang W; Guedj M; Bertrand V; Foucquier J; Jouve E; Commenges D; Proust-Lima C; Murphy NP; Blin O; Magy L; Cohen D; Attarian S
    PLoS One; 2017; 12(1):e0169878. PubMed ID: 28095456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion tensor imaging of the sciatic nerve in Charcot-Marie-Tooth disease type I patients: a prospective case-control study.
    Kim HS; Yoon YC; Choi BO; Jin W; Cha JG; Kim JH
    Eur Radiol; 2019 Jun; 29(6):3241-3252. PubMed ID: 30635758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.